Wisp operates a remote-first telehealth platform dedicated to women’s health, connecting patients with licensed providers for real-time consultations, fast prescriptions, and trusted over-the-counter treatments. The company’s product suite covers the full spectrum of women’s health needs, including birth control, fertility solutions, menopause management, and STI testing. To date, Wisp has served more than 1.8 million patients, positioning it as the largest dedicated women’s telehealth provider in the United States. Its model emphasizes convenience, discretion, and longitudinal care that supports patients throughout every life stage. The firm continues to innovate with first-to-market offerings and is committed to making specialized healthcare broadly accessible. With new capital in hand, Wisp plans to accelerate growth, enhance its technology platform, and expand its service reach. The organization is mission-driven and aims to reshape the future of women’s healthcare through accessible digital solutions.

Total raised

$50M

Funding rounds

1

Latest round

Series B

Latest activity

Jan 2026